Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2019

Advanced Biomedical Technologies, Inc. is engaged in the business of designing, developing, manufacturing, and marketing of biomaterial internal fixation devices. The Company’s primary products include Polymer Osteosynthesis Devices made of a proprietary material compositing of polyamide 6 (PA6), hydroxyapatite (HA) and poly (methyl methacrylate-co-N-vinylpyrrolidone) (P(MMA-co-NVP)). These advanced materials are used in surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, and reconstructive dental procedures. Its PA Binding Wires are under clinical trials and its PA Mini-Screws are under animal test.